logo
U.S. hiring likely slowed to 130,000 new jobs last month amid uncertainty over Trump's policies

U.S. hiring likely slowed to 130,000 new jobs last month amid uncertainty over Trump's policies

WASHINGTON (AP) — The American job market likely continued to slow last month, hobbled by worries over President Donald Trump's trade wars, deportations and purges of the federal workforce.
The Labor Department's numbers on May hiring Friday are expected to show that businesses, government agencies and nonprofits added 130,000 jobs last month. That would be down from 177,000 in April but enough to stay ahead of people entering the workforce and keep the unemployment rate at a low 4.2%, according to a survey of forecasters by the data firm FactSet.
Mainstream economists expect Trump's policies to take a toll on America's economy, the world's largest. His massive taxes on imports – tariffs – are expected to raise costs for U.S. companies that buy raw materials, equipment and components from overseas and force them to cut back hiring or even lay workers off. Billionaire Elon Musk's Department of Government Efficiency (DOGE) has slashed federal workers and cancelled government contracts. Trump's crackdown on illegal immigration is expected to make it harder for businesses to find enough workers.
For the most part, though, any damage has yet to show up in the government's economic data.
The U.S. economy and job market have proven surprisingly resilient in recent years. When the inflation fighters at the Federal Reserve raised their benchmark interest rate 11 times in 2022 and 2023, the higher borrowing costs were widely expected to tip the United States into a recession.
Instead, the economy kept growing and employers kept hiring.
But former Fed economist Claudia Sahm warns that the job market of 2025 isn't nearly as durable as the two or three years ago when immigrants were pouring into the U.S. job market and employers were posting record job openings.
'Any signs of weakness in the data this week would stoke fears of a recession again,' Sahm, now chief economist at New Century Advisors, wrote in a Substack post this week. 'It's too soon to see the full effects of tariffs, DOGE, or other policies on the labor market; softening now would suggest less resilience to those later effects, raising the odds of a recession.''
Recent economic reports have sent mixed signals.
The Labor Department reported Tuesday that U.S. job openings rose unexpectedly to 7.4 million in April – seemingly a good sign. But the same report showed that layoffs ticked up and the number of Americans quitting their jobs fell, a sign they were less confident they could find something better elsewhere.
Surveys by the Institute for Supply Management, a trade group of purchasing managers, found that both American manufacturing and services businesses were contracting last month.
And the number of Americans applying for unemployment benefits rose last week to the highest level in eight months.
Jobless claims — a proxy for layoffs — still remain low by historical standards, suggesting that employers are reluctant to cut staff despite uncertainty over Trump's policies. They likely remember how hard it was to bring people back from the massive but short-lived layoffs of the 2020 COVID-19 recession as the U.S. economy bounced back with unexpected strength.
Still, the job market has clearly decelerated. So far this year, American employers have added an average 144,000 jobs a month. That is down from 168,000 last year, 216,000 in 2023, 380,000 in 2022 and a record 603,000 in 2021 in the rebound from COVID-19 layoffs.
Trump's tariffs — and the erratic way he rolls them out, suspends them and conjures up new ones — have already buffeted the economy. America's gross domestic product — the nation's output of goods and services — fell at a 0.2% annual pace from January through March this year.
A surge of imports shaved 5 percentage points off growth during the first quarter as companies rushed to bring in foreign products ahead of Trump's tariffs. Imports plunged by a record 16% in April as Trump's levies took effect. The drop in foreign goods could mean fewer jobs at the warehouses that store them and the trucking companies that haul them around, wrote Michael Madowitz, an economist at the left-leaning Roosevelt Institute.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 16% Stock Price Surge Over Last Month
CRISPR Therapeutics (NasdaqGM:CRSP) Sees 16% Stock Price Surge Over Last Month

Yahoo

time25 minutes ago

  • Yahoo

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 16% Stock Price Surge Over Last Month

CRISPR Therapeutics experienced a 15.8% increase in its share price over the past month. While specific recent news on the company was not available to credit for this movement, it's worth noting that during this period, the broader market rose by 1.8%, and has seen a 13% increase over the past year. With market earnings projected to grow 14% annually, the strong performance of CRISPR's stock could be viewed alongside these generally positive trends and any recent but unspecified developments as contributing factors to its upward momentum in the market. Be aware that CRISPR Therapeutics is showing 1 weakness in our investment analysis. Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. Over the past year, CRISPR Therapeutics' shares experienced a total return of 27.67% decline. This longer-term performance contrasts with the U.S. market's return of 12.6% and the U.S. Biotechs industry return of 9% over the same period. Despite the recent 15.8% increase in CRISPR's stock price over the past month, the longer-term underperformance highlights ongoing challenges. The company's significant net losses and decreasing revenue signal potential hurdles to achieving forecasted revenue growth of 57.32% per year. Earnings forecasts remain bleak, as CRISPR is currently unprofitable and not expected to turn profitable within the next three years. This indicates that while the recent uptick in share price might be aligned with short-term market trends, the company's underlying financial health presents uncertainties. Analyst consensus estimates a fair value price target of US$81.67, which is over twice the current share price. This suggests that the stock is trading at a substantial discount, potentially implying room for future price appreciation if the company can improve its financial metrics. However, it also underscores the risks, given the current unprofitable status and forecasted challenges ahead. Examine CRISPR Therapeutics' past performance report to understand how it has performed in prior years. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGM:CRSP. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

You can still score the PlayStation DualSense Edge controller at its best-ever price
You can still score the PlayStation DualSense Edge controller at its best-ever price

Yahoo

time27 minutes ago

  • Yahoo

You can still score the PlayStation DualSense Edge controller at its best-ever price

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. SAVE $30.99: As of June 6, the PlayStation DualSense Edge Wireless Controller is on sale for $169 at Amazon. That's 15% off its list price of $199.99 and its lowest price yet. Opens in a new window Credit: PlayStation PlayStation DualSense Edge Wireless Controller $169 at Amazon $199.99 Save $30.99 Get Deal PlayStation's Days of Play is still going strong, as are the many great PlayStation deals available right now. If you've been looking to pick up a new controller for your PS5, or an extra for your next co-op session, the PlayStation DualSense Edge Controller is still down to its lowest-ever price at Amazon. The PlayStation DualSense Edge Controller has received a 15% discount at Amazon that has dropped its price from $199.99 to $169. The deal applies to both the midnight black and white versions of the controller as well, so you can scoop up the one that best matches your PS5 setup. SEE ALSO: Get the PlayStation 5 Pro for its lowest-ever price at Target The DualSense Edge has plenty to offer PS5 players, with stick caps you can change out, adjustable triggers, mappable back buttons, and more to help you personalize how you play. The Days of Play sale runs runs through June 11, so act fast to save on the PlayStation DualSense Edge Controller. If you're looking for the standard DualSense controllers instead, those are also on sale right now. Roku Ultra 4K Ultimate Streaming Player (2024 Release) — $79.99 (List Price $99.99) Beats Pill Bluetooth Speaker — $99.95 (List Price $149.95) Roborock Qrevo Master Robot Vacuum and Mop — $899.99 (List Price $1599.99) Apple AirTag (4-Pack) — $74.99 (List Price $99.00) DualSense Edge Wireless Controller — $169.00 (List Price $199.99)

Shirley Madigan, wife of former House Speaker Mike Madigan, makes video plea to federal judge before his sentencing
Shirley Madigan, wife of former House Speaker Mike Madigan, makes video plea to federal judge before his sentencing

CBS News

time27 minutes ago

  • CBS News

Shirley Madigan, wife of former House Speaker Mike Madigan, makes video plea to federal judge before his sentencing

The wife of former Illinois House Speaker Mike Madigan is pleading with a federal judge before his sentencing next week. Shirley Madigan sent a video about her husband, who was convicted on corruption charges, that she hopes will be played in open court. In the video, she explained that she wouldn't know what to do without him around. "I really don't exist without him. I wish I could say that I do, but I don't know what I will do without Michael. I would probably have to find some place to live, and I probably would have to find care," she said. Mike Madigan was convicted of bribery conspiracy, bribery, and wire fraud charges in February, but was acquitted of several other charges after a four-month trial accusing him of running a years-long criminal enterprise to enrich himself and his political allies. He was convicted on 10 counts and acquitted on seven others, while jurors were deadlocked on six other counts against him. The jury also was unable to reach a unanimous verdict on all six charges against his co-defendant, Michael McClain. The verdict was reached after more than 60 hours of deliberations over 11 days. Madigan and McClain faced a 23-count indictment in federal court in Chicago on charges of racketeering conspiracy, bribery, wire fraud, and attempted extortion. They were accused of conspiring with utility companies ComEd and AT&T to provide no-show jobs to Madigan's allies in exchange for the speaker's help on legislation. Prosecutors also accused Madigan of pressuring real estate developers to hire his private law firm, which specializes in property tax appeals. His sentencing is scheduled for June 13.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store